From the Sector

The corona pandemic continues to put a strain on health systems around the globe. Many places lack effective textile protective kit among others for their medical personnel. HeiQ, a Swiss specialty chemicals company, has developed antiviral and antibacterial protective kit that is quickly effective against Coronaviruses (229E), as confirmed in wide-ranging studies. In cooperation with HeiQ, the CHT Group is supplying this technology to the market to help decrease the global shortage in protective wear.

A wide number of studies have proven that viruses and bacteria can remain active on textile surfaces for a longer period. The SARS-COV-2 virus, which causes the COVID-19 disease, can stay active on a textile for up to two days and therefore be infectious. Shortages in textile protective kit create a high risk for medical personnel who are in contact with COVID-19 patients: often, doctors and nurses cannot change their protective masks and clothing as frequently as would be necessary in order to adhere to hygiene rules and to prevent the spreading of the virus.

The HeiQ Viroblock NPJ03 that has been developed by HeiQ is a new technology that is also effective against Coronaviruses (229E) thanks to its antibacterial and antiviral properties. Comprehensive studies have demonstrated the kit‘s effectiveness. A combination of silver salts with a vesicle technology deactivates bacteria and viruses on textile surfaces within a few minutes and renders the bacteria and viruses harmless. Textiles equipped in this way reduce the rate of infection by 99.99%, which stops the transmission and the spread of bacteria and viruses through textiles.

Viroblock can be used on all types of fibers – not only for protective kit and masks, but also for work clothing, bed linen, towels and home textiles. The kit is wash-resistant and still highly effective after 30 standard wash processes.

Materials for in excess of one million protective masks
Within the context of supporting the critical infrastructure in Germany, Oerlikon Nonwoven immediately began converting its laboratory systems in Neumünster to manufacture nonwovens at the end of March. With this, only small local businesses and companies were initially supported in the manufacture of oronasal masks.
With the laboratory system at the R&D Center material for more than one million protective masks a month can be manufactured.

The laboratory has meanwhile run out of raw materials and new orders for replacement materials had to be placed before Easter – with current delivery times of approx. 3 weeks. This will allow production to be resumed, and even considerably expanded, in May.
The laboratory system is now once again being deployed to produce nonwovens that will be used to make more than million face masks / oronasal masks a month. “We will not be manufacturing the masks ourselves. We have meanwhile found both corresponding partner companies and also private individuals demanding nonwovens”, adds Andreas Frisch, commenting on the developments.

Boom in orders
Furthermore, Oerlikon Nonwoven has also fired up the production of the machines and systems used for its meltblown technology. The demand from Germany, Europe and the rest of the world has quickly
secured the company a high in orders..
We will be commissioning the first meltblown system at the site of a leading Western European nonwovens producers in the second quarter of 2020. The capacities for respiratory masks available in Europe to date are predominantly manufactured on Oerlikon
Nonwoven systems.

Energiapura – Production of reusable, customised protective masks that are also fashion accessories

• The Italian company, a specialist manufacturer of functional sportswear, conducted research and began producing masks in response to the COVID-19 crisis
• Using Mimaki sublimation printers, the masks can be customised, getting away from their connotation with hospitals and transforming them into a fashion accessory

From functional sportswear to combatting the spread of the Coronavirus: Energiapura, an Italian company has developed a mask that meets the Class I medical device requirements. The EP PA 2020 (Energiapura Pure Air) facial device, optimised for air filtering and breathability, provides protection while working, and can be reused. But Energiapura has gone even further, branding and customising the masks with sublimation printing.
The EP PA 2020 mask, compliant with 93/42 EEC Medical Devices – Class I washable, meets the essential requirements of UNI EN 14683:2019. Having redirected the manufacturing process, Energiapura is now stepping up production levels to meet the rising demand from hospitals, pharmacies, chemists, companies and consumers.

Pure Air, Energiapura’s mask
The EP PA 2020 is based on a functional concept: protection, breathability and reusability are the main principles. EP PA 2020 is made up of three layers of fabric: the first, the outer layer, is DWR-treated polyester, the second is TNT polyester, providing a filtering function, and the third, which comes into contact with the face, is polyester containing special fibres, such as coolmax and carbon.  Therefore it can be reused via normal washing and steam ironing, which also sterilises it.
The CEO of Enegiapura, Alberto Olivietto explains the idea of the customisation of the mask: “We wanted to disassociate our masks from the hospital image. By decorating them with company branding and designs provided by customers.” This is where the Mimaki JV300 wide-format printer comes in.

In mid-March, CHT Germany GmbH, which specializes in specialty chemicals, took up production and distribution of hand disinfectant. Now the company is expanding its product portfolio by adding important medical supplies that can help fight Covid-19 (SARS-CoV-2). Starting immediately, CHT is providing its business customers with surface disinfectant, textile supplies for medical protective wear as well as supplies for test kits and face masks.

Following increased demand for disinfectant in the wake of the new coronavirus, the CHT Group began already a month and a half ago to produce hand disinfectant at its factory in Dußlingen. Since then, more of its factories around the world had joined in. Now the CHT Group is complementing this offering by producing its own surface disinfectant based on ethanol. As with the hand disinfectant, the production of the surface disinfectant received a special approval, based on the expanded general ruling by the German Federal Agency  for Chemicals (BAuA). Both types of disinfectant use publicly available standard formulas for alcohol-based disinfectant from the World Health Organization (WHO). The sale of CHT’s surface disinfectant, which is available in 5-, 10- and 30-liter canisters, is exclusively for use by industry customers.

In addition, the CHT Group is manufacturing a range of textile-relevant products that provide protection from Covid-19. These include functional supplies for face masks for medical protective wear, as well as flocking for test kits. Through these offerings, the CHT Group also wants to support the textile sector, which has been strongly affected by the crisis.

• The PREMIUM GROUP in Berlin is cancelling its PREMIUM and SEEK trade shows for this summer season, as well as the FASHIONTECH conference – in collaboration with the leading global digital B2B marketplace, JOOR, there is still a guaranteed trading option.

Due to the coronavirus crisis, in April the dates of the PREMIUM GROUP’s events were provisionally moved from the original schedule of 31 June-2 July 2020 to 28 -30 July. Now, the Federal and State governments have decided to cancel large-scale events with over 1,000 visitors until 31 August 2020.
     
A statement from Anita Tillmann, Managing Partner of the PREMIUM GROUP: 

“We greatly regret the decision of course, especially after the success of our January events. The ban on large-scale events has been around for some time and has been publicly discussed. It hurts us to do it, but we are also conscious of our responsibility. If cancelling our trade shows, conferences and parties contributes to the safety of our customers and visitors, then we have to take this step.
 
We are in close contact with all our brands and partners and have spent the last four weeks discussing possible approaches, concepts and new focal topics for the summer. The bottom line is that digitalisation is clearly the focus. It’s all about using the time over the next few months sensibly. The timing for brands and retailers is now right – all market participants are aware of the necessity of this.

We have been working closely with JOOR, the leading B2B marketplace globally, for around a year, after successfully integrating our own digital platform, Veee.com. JOOR has digitalised the entire procurement process and ensures a seamless, functioning wholesale process on an international scale – both for brands and retailers.
 
We shall shortly be offering webinars on this and can offer our customers an optimal, digital ordering solution so as to use this time of the pandemic efficiently. We are very happy with this option and our year-long investment in the topic of digitalisation. This has come good for us now.
 
Our trade show formats have been about more than just ordering for a long time now. They are about encounters, emotion, inspiration, communication and, finally, the fashion community getting together. Although lots can take place digitally nowadays, it doesn't replace physically meeting up in person. We have seen this more than ever in the present situation.
 
We are going to work on new concepts for 2021, and we will liaise with the key stakeholders in Berlin and with all others too to ensure we hit the ground running again. We’re taking on the challenge and will come back to the industry when we have news.”

• All motions approved
• Dividend of CHF 4.50 agreed
• COVID-19

In relation to participation in the Annual General Meeting on April 16, 2020, the Board of Directors of Rieter Holding Ltd. arranged exclusively written or electronic voting and the granting of power of attorney to the independent proxy. In taking this approach, the Board of Directors relied on Article 6a, lit. b of Ordinance 2 of the Swiss Federal Council (Measures to Combat the Coronavirus of March 16, 2020). Physical participation by the shareholders was therefore not possible. The Annual General Meeting was held on the premises of Rieter Holding Ltd. at the company’s headquarters in Winterthur.

At the Annual General Meeting of Rieter Holding Ltd. on April 16, 2020, the independent proxy represented a total of 2 025 shareholders who hold 64.3% of the share capital.

A dividend of CHF 4.50 per share was agreed. The shareholders approved the proposed maximum total amounts of the remuneration of the members of the Board of Directors and of the Group Executive Committee for fiscal year 2021.

The Chairman of the Board, Bernhard Jucker, and the members of the Board of Directors This E. Schneider, Michael Pieper, Hans-Peter Schwald, Peter Spuhler, Roger Baillod, Carl Illi and Luc Tack were confirmed for an additional one-year term of office.
Furthermore, This E. Schneider, Hans-Peter Schwald and Bernhard Jucker, the members of the Remuneration Committee who were standing for election, were also each re-elected for a one-year term of office.

Shareholders also adopted all other motions proposed by the Board of Directors, namely approval of the annual report, the financial statements and the consolidated financial statements for 2019, and formal approval of the actions of the members of the Board of Directors and those of the Group Executive Committee in the year under review. In addition, the authorized capital was extended for a further two years.

COVID-19
At present, it is not possible to predict how the global COVID-19 pandemic will affect Rieter’s sales and earnings in the first and second half of 2020, and thus also for 2020 as a whole.

Rieter therefore refrains from providing an outlook for financial year 2020 and will issue the relevant information as part of the semi-annual report on July 16, 2020.
The company has taken the necessary measures to protect employees and to meet commitments to customers as far as possible.

Thanks to long-standing customer relationships, a focus on innovation, global positioning and the company’s financial stability, Rieter will successfully overcome the challenges.

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99 %.

Swiss company SANITIZED AG celebrates validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019).
Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2.

Patented technology featuring an ammonium silicate compound is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology. These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses.
The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE

SANITIZED AG has been supporting the work of hygienists in hospitals, doctor’s offices, nursing and care facilities for many years with its antimicrobial - and now also antiviral - additives used to enhance the
functionality of textiles and polymers. The reduction of bacteria and viruses is a feasible way to help stem the spread of infections including MRSA.

The previously communicated targets for 2020 are unlikely to be achieved due to the COVID-19 pandemic

The Board of Management of SGL Carbon SE determined today, that the forecasted results for the fiscal year 2020 are unlikely to be achieved due to the global COVID-19 pandemic. In light of the substantial uncertainty regarding the duration and the consequences of the COVID-19 pandemic, the Board of Management is currently unable to provide a reliable sales revenue and earnings forecast for the current year. Consequently, the guidance for 2020 is suspended. 

The previous expectation, which guided for a slightly lower sales revenue und a recurring EBIT1 approximately 10-15% below the prior year (sales revenue 2019: €1,087m; recurring EBIT 2019: €48m), was already made conditional by the Board of Management in the management report published on March 12, 2020, that negative effects from the coronavirus were not included, as the outbreak at that time was mainly restricted to China and Italy. In the meantime, numerous other governments have introduced far-reaching measures with substantial limitations on the public and economic sectors and leading economists now forecast significant reductions in economic output in key economies. 

The Board of Management of SGL Carbon has introduced and partially already implemented comprehensive measures to reduce the cost base and to secure liquidity. These measures include the introduction of short-time work, reduction of material and indirect spend, as well as further reduction resp. postponement of capital expenditures. In addition, we are exploring further financing options independent of the capital markets, some of which are already in preparation. The Company is intensively working on identifying and mitigating potential risks. 

Perlon®, A Serafin Group company is continuing to produce its’ quality filaments at all five sites for its’ customers in the current challenging climate. Production in China has been operating again as normal since the beginning of March after having to be temporarily halted due to the spreading of COVID-19. Production is now back up to 100%.

Production in Germany at our sites in Munderkingen (Baden-Wuerttemberg), Bobingen (Bavaria) and Wald-Michelbach (Hesse) as well as in the USA is continuing to run without any constraints. Therefore all sites are working to full capacity to fulfill all our customer orders. In particular, in the paper machine clothing area is showing an increase in sales which offsets a reduced demand in other areas such as automotive.

In the current situation, the company is doing everything it can to fulfill its’ responsibility as an employer and also as a business partner. Therefore all hygiene measures at all our sites have been significantly increased so that our employees are protected as well as possible. There is hand sanitizer in every department and all of our production lines are disinfected several times a day. It has been explained to employees, what they should do in the current climate in order to minimize risk. Where possible employees are able to work from home. Perlon® has approximately 650 employees in Germany, over 80 in the USA and more than 100 in China.

High demand for monofilament for the paper industry.

The paper industry is currently experiencing a rise in demand worldwide – and Perlon® is also benefitting from this, as customers need even more high-quality monofilament and twisted yarns for the tensioning of paper machines. For the paper machine clothing field, Perlon® produced filaments are used to manufacture press fabric, which can be used either as a conveyor belt or for moisture removal on a paper production line. Due to the high mechanical strain through the presses, polyamide monofilaments or twisted yarns are therefore almost always used. Paper industry customers have increased their production recently. Whether it’s boxes to cope with the increased demand for online deliveries or paper for hygiene purposes (which everybody can identify with), there is an increased demand worldwide. The dental, hygiene and food preparation fields are also experiencing increased demand. To this end, Perlon® offers filaments for the manufacture of toothbrushes and high-quality cleaning system brushes.

Mitglieder der europäischen Normungsorganisationen CEN und CENELEC unterstützen Kampf gegen Corona-Krise

Die europäischen Normungsorganisationen CEN und CENELEC haben mit dem Einverständnis all ihrer Mitglieder – darunter DIN (Deutsches Institut für Normung) – und in Absprache mit der Europäischen Kommission entschieden, eine Reihe von Europäischen Normen für Medizinprodukte und persönliche Schutzausrüstung kostenlos zur Verfügung zu stellen, um damit die Bekämpfung der COVID-19-Pandemie zu unterstützen.
Ziel ist es, dem wachsenden Mangel an Schutzmasken, -handschuhen und weiteren Produkten zu begegnen, mit dem viele europäische Länder derzeit zu kämpfen haben. Mit der Bereitstellung der Normen soll Unternehmen geholfen werden, die ihre Produktlinien umstellen wollen, um die so dringend benötigte Ausrüstung kurzfristig herzustellen. Die Normen richten sich rein an professionelle Anwende

Darüber hinaus wird auch die internationale Normungsorganisation ISO relevante Standards für medizinische Ausrüstung zur Verfügung stellen. Bis auf weiteres werden die Normen in der aktuellen Version kostenfrei zur Verfügung gestellt. Diese Normen beschreiben wesentliche Anforderungen an Filtermasken, medizinische Handschuhe und Schutzkleidung.
Interessierte Unternehmen und Organisationen können die Normen im Webshop des Beuth Verlags unter www.beuth.de/go/kostenlose-normen herunterladen.

Zur Verfügung gestellt werden Normen für unter anderem Schutzmasken, Handschuhe und Schutzkleidung.
Weitere kostenfreie Standards stellen auch die US-Regelsetzer AAMI (Association for the Advancement of Medical Instrumentation) und ASTM International zur Verfügung:

• https://www.aami.org/newsviews/content.aspx?ItemNumber=12222
• https://www.astm.org/COVID-19/